Tandem Diabetes Care Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript
Hi, everyone. This is Steve Lichtman, Medical Devices Analyst at Oppenheimer. Welcome back to the Oppenheimer Fall Healthcare summit. Very happy to have with us up next Tandem Diabetes, a leader in the insulin pump market. With us today are John Sheridan, President and CEO; Susan Morrison, EVP and CIO, and Liz Gasser, EVP and Chief Strategy Officer. This will be a fireside format. If you have any questions, please submit them, and I'll get them over to the management team. I am going to turn it over to John for a few opening comments. And then again, we'll go right into questions. Thanks John.
Sure. Steve, it's great to be here. It's good to see you. We're looking forward to these meetings being in person in the future. I just want to start off by saying that we are continuing to see great momentum with Control-IQ in the market. And in the US, it's been in the market now for approximately
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
